Your browser doesn't support javascript.
loading
Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life-threatening gastrointestinal bleed.
Nummi, Vuokko; Lehtinen, Elina; Mäkipernaa, Anne; Szanto, Timea; Lassila, Riitta.
Afiliação
  • Nummi V; Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Lehtinen E; Coagulation Disorder Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Mäkipernaa A; Coagulation Disorder Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Szanto T; Coagulation Disorder Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Lassila R; Coagulation Disorder Unit, Department of Clinical Chemistry, HUSLAB Laboratory Services, Helsinki University Hospital, Helsinki, Finland.
Haemophilia ; 25(4): e291-e293, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31050121
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Doença de von Willebrand Tipo 3 / Hemorragia Gastrointestinal / Isoanticorpos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Doença de von Willebrand Tipo 3 / Hemorragia Gastrointestinal / Isoanticorpos Idioma: En Ano de publicação: 2019 Tipo de documento: Article